Note: Ingredients listed on restricted chemical lists
EC/CAS
201-069-1/77-92-9
Name of the chemical
Citric acid
Concentration
45-70
EC/CAS
203-742-5/110-16-7
Name of the chemical
Maleic acid
Concentration
30-60
EC/CAS
270-325-2/68424-85-1
Name of the chemical
Alkyl (C12-16) dimethylbenzyl ammonium chloride
Concentration
0.1-1
General Information
Version
1.1
Revision date
2022-04-08
Product name
Milk System Cleaning Tablets
Manufacturer Name
Urnex Brands, LLC
Emergency telephone
+1 (352) 323-3500, +(353) 1-809-2166
Icons in SDS
Company Information
company name
Urnex Brands, LLC
e-mail address of the competent person responsible for the Safety Data Sheet
info@urnex.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Hazard statements
see section 16 : H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H335 - May cause respiratory irritation.
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Contains
Maleic acid
Precautionary statements
P261 - Avoid breathing dust. P264 - Wash hands thoroughly after handling. P280 - Wear eye protection, protective gloves. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse. P403+P233 - Store in a well-ventilated place. Keep container tightly closed. Child-resistant fastening : Not applicable Tactile warning : Not applicable
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %